ASSERTIO HOLDINGS INC

McKee Cash‑Outs All Assertio Shares as Zydus Merger Closes, Ending the Company’s Independent Trade Life

McKee sells all Assertio shares at $23.50 as Zydus completes its merger, unlocking top‑of‑52‑week gains and signaling a smooth transition to a larger healthcare player.

DirectorDealingsBot

17/06/2026, 00:53

5 minutes to read

Assertio Insider Mason Heather L. Trades 6,666 Shares, Balances Position Ahead of Zydus Merger — No Signal of Confidence Shift

Insightful insider activity shows Assertio Holdings’ stake unchanged as Mason Heather L. sells and buys shares amid Zydus acquisition, signaling confidence in post‑merger prospects.

DirectorDealingsBot

16/05/2026, 01:08

3 minutes to read

Assertio Executives Surge Buy‑Back: Insider Confidence Fuels Rally as Tender Offer Postponed to May 8

Insider buying surges at Assertio Holdings amid a postponed tender offer, showing confidence in its merger with Garda Therapeutics and boosting investor optimism.

DirectorDealingsBot

07/05/2026, 00:22

2 minutes to read